Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-22

FDA Approved: BELBUCA — Supplemental Application (BioDelivery Sciences International Inc)

View source ↗

Summary

The FDA approved a supplemental application for Belbuca (buprenorphine hydrochloride) from BioDelivery Sciences International Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BELBUCA (Buprenorphine hydrochloride)

Snippet

SUPPL AP for BELBUCA (BUPRENORPHINE HYDROCHLORIDE)